ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,325Medicare Part D Prescriptions Filled, Including Refills

Rank: 130 out of 807

$334K Total Retail Price of All Prescriptions

Rank: 285 out of 807

488 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 488 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 7,739 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
FUROSEMIDE 352 352 1 6
SIMVASTATIN 349 320 2 1
OMEPRAZOLE 331 272 3 4
LISINOPRIL 316 293 4 2
LEVOTHYROXINE SODIUM 276 266 5 3
ATENOLOL 257 255 6 7
PREDNISONE 256 230 7 24
METOPROLOL TARTRATE 216 208 8 8
TRIAMTERENE-HCTZ 215 210 9 29
POTASSIUM CHLORIDE 186 186 10 18
HYDROCODONE-ACETAMINOPHEN 174 134 S3 11 15
AMLODIPINE BESYLATE 168 168 12 5
WARFARIN SODIUM 149 144 13 10
HYDROCHLOROTHIAZIDE 148 145 14 9
DIGOXIN 129 129 15 41
METFORMIN HCL 125 121 16 12
ALLOPURINOL 119 108 17 26
METHOTREXATE 117 83 18 86
TRAMADOL HCL 113 100 19 19
LOSARTAN POTASSIUM 105 102 20 14
SERTRALINE HCL 96 90 21 22
CLONIDINE HCL 86 86 22 82
JANTOVEN 85 78 23 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 81 24 28
DILTIAZEM 24HR CD 75 75 25 76
GLYBURIDE 72 72 R 26 80
KLOR-CON 10 70 70 27 81
GLIMEPIRIDE 66 66 28 51
RANITIDINE HCL 66 53 28 34
LOVASTATIN 64 60 30 39
HYDROXYCHLOROQUINE SULFATE 62 55 31 146
CITALOPRAM HBR 62 60 31 17
METOPROLOL SUCCINATE 61 61 33 13
ATORVASTATIN CALCIUM 61 59 33 11
ACTOS 60 57 35 151
PAROXETINE HCL 59 35 36 49
ALENDRONATE SODIUM 58 58 37 20
RAMIPRIL 55 55 38 131
LOSARTAN-HYDROCHLOROTHIAZIDE 55 55 38 55
DILTIAZEM ER 53 53 40 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.